Skip to main content
. Author manuscript; available in PMC: 2022 Jul 30.
Published in final edited form as: Pharmacotherapy. 2021 Nov 17;42(1):14–22. doi: 10.1002/phar.2641

FIGURE 1.

FIGURE 1

Clearance of alemtuzumab over time. Alemtuzumab levels for each patient were plotted at days 7, 14, 21, and 28 after the transplant. Average alemtuzumab levels for patients who received Alem-TBI (solid line) or Pento-Cy-Alem-TBI (dashed line) are shown. Day 7 levels were significantly lower in the Alem-TBI group (p < 0.001), but less significant at the later time points, compared with the Pento-Cy-Alem-TBI group